{"id":15661,"date":"2016-01-22T08:32:46","date_gmt":"2016-01-22T08:32:46","guid":{"rendered":"http:\/\/virgo.pravo.hr\/intvla\/www\/wordpress\/?page_id=15661"},"modified":"2019-05-30T23:30:21","modified_gmt":"2019-05-30T21:30:21","slug":"patenti-u-biotehnologiji","status":"publish","type":"page","link":"https:\/\/intvla.unizg.hr\/index.php\/patenti-u-biotehnologiji\/","title":{"rendered":"Patenti u biotehnologiji"},"content":{"rendered":"

[vc_row row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” padding_bottom=”25″ css_animation=””][vc_column][vc_column_text]<\/p>\n

Patenti u podru\u010dju biotehnologije<\/h3>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” padding_bottom=”75″ css_animation=””][vc_column width=”2\/3″][vc_accordion active_tab=”1″ collapsible=”yes” style=”boxed_toggle”][vc_accordion_tab title=”Ciljevi predmeta”][vc_column_text]Cilj predmeta je osposobiti studente\/ice za rje\u0161avanje problema povezanih s razvojem i za\u0161titom izuma u podru\u010dju biotehnologije.[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=”Sadr\u017eaj predmeta i satnica”][vc_column_text]a) uvod u biotehnologiju – razvoj bioprocesa i bioproizvoda (2 sata)<\/p>\n

b) predmeti i izuzeci za\u0161tite u podru\u010dju biotehnologije – pregled (1 sat)<\/p>\n

c) patentna za\u0161tita u podru\u010dju bioprocesnog in\u017eenjerstva i industrijske mikrobiologije (1 sat)<\/p>\n

d) patentiranje nukleinskih kiselina, gena, vektora, stani\u010dnih linija (1 sat)<\/p>\n

e) patentiranje transgeni\u010dnih \u017eivotinja i biljaka, mati\u010dnih stanica, genska terapija, cjepiva, hormoni, biomaterijali u tkivnom in\u017eenjerstvu (2 sata)<\/p>\n

g) sastavljanje patentnih zahtjeva u biotehnologiji – primjeri (2 sata)<\/p>\n

h) poslovni aspekti za\u0161tite izuma u podru\u010dju biotehnologije (1 sat)[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=”Literatura”][vc_column_text]Obvezna literatura<\/strong><\/p>\n

[\/vc_column_text][vc_empty_space][vc_column_text]<\/p>\n

1.\u00a0\u00a0\u00a0\u00a0 Zakon o patentu NN 173\/03, 87\/05, 76\/07, 30\/09, 128\/10, 49\/11<\/p>\n

2.\u00a0\u00a0\u00a0\u00a0 Pravilnik o patentu NN 117\/07, 03\/11, 66\/11<\/p>\n

3.\u00a0\u00a0\u00a0\u00a0 Ugovor o suradnji na podru\u010dju patenata NN 3\/98 i 10\/98<\/p>\n

4.\u00a0\u00a0\u00a0\u00a0 Pravilnik prema Ugovoru o suradnji na podru\u010dju patenata (PCT) NN 10\/98, 3\/01, 4\/02, 15\/02, 1\/03, 18\/03, 3\/05, 3\/06, 5\/08, 12\/08, 5\/09, 4\/10, 9\/11<\/p>\n

5.\u00a0\u00a0\u00a0\u00a0 Europska patentna konvencija 2000 (EPC 2000) NN 8\/07 i 1\/08<\/p>\n

6.\u00a0\u00a0\u00a0\u00a0 Provedbeni pravilnik Europske patentne konvencije 2000. usvojen odlukom Upravnog vije\u0107a od 7. prosinca 2006. godine koje je sastavni dio Europske patentne konvencije kako je izmijenjena i dopunjena NN 13\/09<\/p>\n

7.\u00a0\u00a0\u00a0\u00a0 Zakon o potvr\u0111ivanju Sporazuma o primjeni \u010dlanka 65. Konvencije o priznavanju europskih patenata (Londonski sporazum) NN 8\/07 i 4\/08<\/p>\n

8.\u00a0\u00a0\u00a0\u00a0 Strasbur\u0161ki sporazum o me\u0111unarodnoj klasifikaciji patenata NN 11\/99 i 4\/00<\/p>\n

9.\u00a0\u00a0\u00a0\u00a0 Budimpe\u0161tanski ugovor o me\u0111unarodnom priznavanju depozita mikroorganizama za potrebe patentnog postupka NN 11\/99 i 4\/00<\/p>\n

10.\u00a0 Ugovor o patentnom pravu (PLT) NN 10\/04 i 3\/05<\/p>\n

11.\u00a0 Zakon o upravnim pristojbama na podru\u010dju intelektualnog vlasni\u0161tva NN 64\/00, 160\/04, 62\/08, 30\/0, 49\/11<\/p>\n

12. \u00a0Zakon o zastupanju u podru\u010dju prava industrijskog vlasni\u0161tva NN 54\/05, 49\/11[\/vc_column_text][vc_empty_space][vc_column_text]Dopunska literatura<\/strong><\/p>\n

[\/vc_column_text][vc_empty_space][vc_column_text]<\/p>\n

1.\u00a0\u00a0\u00a0\u00a0\u00a0 Y. KO, An Economic Analysis of Biotechnology Patent Protection, in 102 Yale L. J., 1992, 777 ff.<\/p>\n

2.\u00a0\u00a0\u00a0\u00a0\u00a0 L. WESTERLUND, Biotech Patents. Equivalency and Exclusions under European and U.S. Patent Law, Kluwer, The Hague, 2002.<\/p>\n

3.\u00a0\u00a0\u00a0\u00a0\u00a0 H.C. WEGNER, Patent Law in Biotechnology, Chemicals and Pharmaceuticals, Stockton, New York, 1994.<\/p>\n

4.\u00a0\u00a0\u00a0\u00a0\u00a0 E.S. VAN DE GRAAF, Patent Law and Modern Biotechnology: A Comparative Study about the Requirements and the Scope of Protection, Sanders Institute, Rotterdam, 1997.<\/p>\n

5.\u00a0\u00a0\u00a0\u00a0\u00a0 P. DUCOR, Patenting the Recombinant Products of Biotechnology, Kluwer, The Hague, 1997.<\/p>\n

6.\u00a0\u00a0\u00a0\u00a0\u00a0 S.J.R. BOSTYN, Enabling Biotechnological Inventions in Europe and the United States. A study of the patentability of proteins and DNA sequences with special emphasis on the disclosure requirement, European Patent Office, Munich, 2001.<\/p>\n

7.\u00a0\u00a0\u00a0\u00a0\u00a0 L. WESTERLUND, Biotech Patents. Equivalency and Exclusions under European and U.S. Patent Law, Kluwer, The Hague, 2002.<\/p>\n

8.\u00a0\u00a0\u00a0\u00a0\u00a0 S.J.R. BOSTYN, A European Perspective on the Ideal Scope of Protection and the Disclosure Requirements for Biotechnological Inventions in a Harmonised Patent System. The Quest for the Holy Grail? in 5 JWIP 2002, 1013 ff.<\/p>\n

9.\u00a0\u00a0\u00a0\u00a0\u00a0 V. SANTANIELLO, Intellectual Property Rights of Plant Varieties and of Biotechnology in the EU, in V. SANTANIELLO-R.E. EVENSON-D. ZILBERMAN-G.A. CARLSON (eds.), Agriculture and Intellectual Property Rights: Economic, Institutional and Implementation Issues in Biotechnology, CABI Publishing, Oxon and New York, N.Y., 2000 (PRIV 2612), 27 ff.<\/p>\n

10.\u00a0\u00a0\u00a0 Matthew Rimmer, Intellectual Property and Biotechnology. Biological Inventions, Edward Elgar, Cheltenham, 2008.<\/p>\n

11.\u00a0\u00a0\u00a0 Han Somen (ed.), The Regulatory Challenge of Biotechnology. Human Genetics, Food and Patents, Edward Elgar, Cheltenham, 2007.<\/p>\n

12.\u00a0\u00a0\u00a0 Oliver Mills, Biotechnological Inventions: Moral Restraints and Patent Law, Ashgate, 2005.<\/p>\n

13.\u00a0\u00a0\u00a0 Suzanne L.W. Wisniewski, Effects of Foreign Intellectual Property Rights on U.S. Bilateral Exports of Biotechnolology-Related Agricultural Inputs, 8 JWIP (2005).<\/p>\n

14.\u00a0\u00a0\u00a0 S. Safrin, Hyperownership in a Time of Biotechnological Promise: the International Conflict to Control the Building Blocks of Life, in 98 Am. J. Int. L. 2004, 641-686.<\/p>\n

15.\u00a0\u00a0\u00a0 L.J. Demaine-A.X. Fellmeth, Reinventing the Double Helix: A Novel and Nonobvious Reconceptualization of the Biotechnology Patent, in 55 Stanford Law Rev. 2002, 303-462 ss.<\/p>\n

16.\u00a0\u00a0\u00a0 T. SAMPSON, Rewriting the Genetic Code: the Impact of Novel Nucleotides on Biotechnology Patents, in 24 EIPR 2002, 409 ff.<\/p>\n

17.\u00a0\u00a0\u00a0 F. FUKUYAMA, Our Posthumous Future. Consequences of the Biotechnology Revolution, Farrar, Straus and Giroux, New York, 2002.<\/p>\n

18.\u00a0\u00a0\u00a0 E.R. GOLD-A. GALLOCHAT, The European Biotech Directive: Past as a Prologue, in Eu L.J., 2001, 331 ff.<\/p>\n

19.\u00a0\u00a0 R. TESCHEMACHER, The Practice of the European Patent Office regarding the Grant of Patents for biotechnological Inventions, in 19 I.I.C. 1988, 18 ff.<\/p>\n

20.\u00a0\u00a0\u00a0 S.J.R. BOSTYN, Enabling Biotechnological Inventions in Europe and the United States. A study of the patentability of proteins and DNA sequences with special emphasis on the disclosure requirement, European Patent Office, Munich, 2001.<\/p>\n

21.\u00a0\u00a0\u00a0 G. KAMSTRA-M. DOERING-N. SCOTT-RAM-A. SHEARD-H. WIXON, Patents on Biotechnological Inventions: The EC Directive \u2013 Special Report, Sweet & Maxwell, London, 2001.<\/p>\n

22.\u00a0\u00a0\u00a0 S. D. MURPHY, Biotechnology and International Law, in 42 Harvard Int. L. Journal, 2001, 47 ff.<\/p>\n

23.\u00a0\u00a0\u00a0 V. SANTANIELLO-R.E. EVENSON-D. ZILBERMAN-G.A. CARLSON (eds.), Agriculture and Intellectual Property Rights: Economic, Institutional and Implementation Issues in Biotechnology, CABI Publishing, Oxon and New York, N.Y., 2000.<\/p>\n

24.\u00a0\u00a0\u00a0 D.D. EVENSON, Patent and Other Private Legal Rights for Biotechnology Inventions, in V. SANTANIELLO-R.E. EVENSON-D. ZILBERMAN-G.A. CARLSON (eds.), Agriculture and Intellectual Property Rights: Economic, Institutional and Implementation Issues in Biotechnology, CABI Publishing, Oxon and New York, N.Y., 2000 (PRIV 2612), 11 ff.<\/p>\n

25.\u00a0\u00a0\u00a0 P. DUCOR, Patenting the Recombinant Products of Biotechnology, Kluwer, The Hague, 1997 (PRIV 471).<\/p>\n

26.\u00a0\u00a0\u00a0 T. Sampson, Achieving Ethically Acceptable Biotechnology Patents: A Lesson from the Clinical Trials Directive? in EIPR 2003, 419-425.<\/p>\n

27.\u00a0\u00a0\u00a0 Ph. W. GRUBB, Patents for Chemicals, Pharmaceuticals and Biotechnology. Fundamentals of Global Law, Practice and Strategy, Oxford University Press, Oxford, 1999 (PRIV 1398).<\/p>\n

28.\u00a0\u00a0\u00a0 B. DOMEIJ, Pharmaceutical Patents in Europe, Kluwer Law International, 2000 (PRIV 2296).<\/p>\n

29.\u00a0\u00a0\u00a0 W.L. Hayhurst, Validity and Infringement of Claims for Pharmaceutical Formulations and their Use, in EIPR 2004, 226-228.<\/p>\n

30.\u00a0\u00a0\u00a0 B. DOMEIJ, Patent Claim Scope: Initial and Follow-on Pharmaceutical Inventions, in 23 EIPR 2001, 326 ff.<\/p>\n

31.\u00a0\u00a0\u00a0 J. R. THOMAS, On Preparatory Texts and Proprietary Technologies: the Place of Prosecution Histories in Patent Claim Interpretation, in 47 UCLA Law Review, 1999, 183 ff.<\/p>\n

32.\u00a0\u00a0\u00a0 J. HUDSON, Generic Take-Up in Pharmaceutical Markets Following Patent Expiry: A Multy Country Study, in 20 Int. Rev. of Law & Economics, 2000, 205 ff.<\/p>\n

33.\u00a0\u00a0\u00a0 L. BRAZELL, The Protection of Pharmaceutical Products and Regulatory Data: EU Enlargement Update, in 24 EIPR 2002, 155 ff.<\/p>\n

34.\u00a0\u00a0\u00a0 W. McARTHUR, Intellectual Property Righs and the Pharmaceutical Industry: the Consequence of Incomplete Protection, O. LIPPERT, Competitive Strategies for Intellectual Property Protection, Vancouver, BC, The Fraser Institute, 1999, 85 ff.<\/p>\n

35.\u00a0\u00a0\u00a0 P. Rey-J.S. Venit, Parallel trade and pharmaceuticals: a policy in search of itself, in 29 Eu. L. R. 2004, 153-177.<\/p>\n

36.\u00a0\u00a0\u00a0 R.S. Eisenberg, Patents, Product Exclusivity, and Information Dissemination: How Law Directs Biopharmaceutical Research and Development, in 72 Fordham L.R. 2003, 477-491.<\/p>\n

37.\u00a0\u00a0\u00a0 P. Rey-J.S. Venit, Parallel trade and pharmaceuticals: a policy in search of itself, in 29 Eu. L. R. 2004, 153-177.<\/p>\n

38.\u00a0\u00a0\u00a0 C. Heath, Parallel Imports of Patented Pharmaceuticals from the New EU Accession States, in 35 IIC 2004, 776-787.<\/p>\n

39.\u00a0\u00a0\u00a0 C.T. Feddersen, Parallel Trade in Pharmaceutical in a Europe of 25: What the Specific Mechanism Achieves and What It Does Not, in EIPR 2003, 545-555.<\/p>\n

40.\u00a0\u00a0\u00a0 S. VASTANO VAUGHAN, Compulsory Licensing of Pharmaceuticals Under TRIPs: What Standards of Compensation? in 25 Hastings International and Comparative Law Review, 2001, 87 ff.<\/p>\n

41.\u00a0\u00a0\u00a0 S. VASTANO VAUGHAN, Compulsory Licensing of Pharmaceuticals Under TRIPs: What Standards of Compensation? in 25 Hastings International and Comparative Law Review, 2001, 87 ff.<\/p>\n

42.\u00a0\u00a0\u00a0 R. Dinka, The \u201cBermuda Triangle\u201d of Pharmaceutical Law in JWIP 2005, 517 ff.<\/p>\n

43.\u00a0\u00a0\u00a0 P. M. DORAN: Bioprocess Engineering Principles, Academic Press, 1998.<\/p>\n

44. \u00a0 \u00a0V. MARI\u0106, B. \u0160ANTEK: Biokemijsko in\u017eenjerstvo, Golden marketing-Tehni\u010dka knjiga, Zagreb, 2009[\/vc_column_text][\/vc_accordion_tab][vc_accordion_tab title=”Ishodi u\u010denja”][vc_column_text]Ishodi u\u010denja na razini programa kojima predmet doprinosi<\/strong><\/p>\n

[\/vc_column_text][vc_empty_space][vc_column_text]<\/p>\n

Nakon odslu\u0161anog predmeta i polo\u017eenog pismenog i usmenog ispita iz ovog predmeta, student\/ica je osposobljen\/a rje\u0161avati prakti\u010dne probleme i pitanja srednje razine slo\u017eenosti, vezane uz razvoj i za\u0161titu izuma u podru\u010dju biotehnologije. Detaljna obradba pojedinih primjera za\u0161tite izuma usmjerena je ka osposobljavanju studenata\/ica za rje\u0161avanje prakti\u010dnih zadataka vezanih uz stjecanje i iskori\u0161tavanje patenata u biotehnologiji te pravnu za\u0161titu. Ovaj predmet objedinjava znanja ste\u010dena u obveznom predmetu Patentno pravo s ovoga studija i nadogra\u0111uje i usmjerava osnovna znanja iz patentnog prava ka patentnom sustavu u biotehnologiji<\/p>\n

[\/vc_column_text][vc_empty_space][vc_column_text]Ishodi u\u010denja na razini predmeta<\/strong><\/p>\n

[\/vc_column_text][vc_empty_space][vc_column_text]<\/p>\n